VirTech Bio Expands Scientific Advisory Board with Medical and Industry Leaders
We are happy to announce the expansion of our Scientific Advisory Board with two esteemed professionals and leaders in their fields.
News
A Successful 2022 for Our Team, and the Advancement of OxyBridge
As we begin the new year, I would like to share the significant progress we have made during 2022.
VirTech Bio presenting at the Florida Venture Summit Dec. 6, 2022
COL(R) Dallas Hack, MD, CEO of VirTech Bio, will present the advancements of OxyBridge™ at the Florida Venture Summit in Miami.
Startup creates ‘artificial blood’ and receives funding from the Pentagon
Solution is tested to give an organ donated for transplant longer survival and to help victims of accidents
Português
Startup cria ‘sangue artificial’ e recebe aporte do Pentágono
Solução é testada para dar maior sobrevida a órgão doado para transplante e para socorrer acidentados
Dr. Dallas Hack Appointed as CEO of VirTech Bio
VirTech Bio, creators of OxyBridge™, announced the appointment of COL(R) Dallas Hack, MD, as their new CEO, March 17, 2022.